Medtronic (MDT)
NYSE:MDT

Medtronic Stock Forecast & Price Target

4,129 Followers
See the Price Targets and Ratings of:

Analyst Rating Consensus

Hold
20Ratings
5 Buy
14 Hold
1 Sell
Based on 20 analysts giving stock ratings to
Medtronic
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MDT Stock Price Prediction

Average Price Target

$87.50
▲(10.59% Upside)
Based on 20 Wall Street analysts offering 12 month price targets for Medtronic in the last 3 months. The average price target is $87.50 with a high forecast of $102.00 and a low forecast of $80.00. The average price target represents a 10.59% change from the last price of $79.12.
Highest Price Target$102.00Average Price Target$87.50Lowest Price Target$80.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Mizuho Securities
$100.00
Buy
26.39%
Upside
Reiterated
We are lowering our FY'23 outlook to $30.5bn/$5.29 (prior $31.4bn/$5.48) reflecting, among other items: 1) continued sluggishness in select procedure categories due to staffing headwinds lingering into mid-next year, 2) China VBP tender headwinds in stapling & cardiac ablation, and 3) stickiness in JNJ Surgical share extending through FY'23 year-end. Despite another setback testing our Buy thesis, we continue to see ample offsets coming from key launches (e.g. Renal Denervation (RDN), Diabetes) as well as follow-on shifts from its ongoing portfolio transformation efforts. With shares at a new multi-year low of ~12.8x forward EBITDA, we see the deep discount as an attractive entry for longer-term capital early next year.
Wolfe Research
$80.00
Sell
1.11%
Upside
Reiterated
Medtronic, Inc. (MDT) PT Lowered to $80 at Wolfe ResearchWolfe Research analyst Mike Polark lowered the price target on Medtronic, Inc. (NYSE: MDT) to $80.00 (from $85.00) while maintaining a Underperform rating.
Cowen & Co.
$90.00
Buy
13.75%
Upside
Reiterated
Medtronic price target lowered to $90 from $117 at CowenMedtronic price target lowered to $90 from $117 at Cowen
Deutsche Bank
$80.00
Hold
1.11%
Upside
Reiterated
Medtronic price target lowered to $80 from $85 at Deutsche BankMedtronic price target lowered to $80 from $85 at Deutsche Bank
RBC Capital
$102.00
Buy
28.92%
Upside
Reiterated
Medtronic, Inc. (MDT) PT Lowered to $102 at RBC CapitalRBC Capital analyst Shagun Singh lowered the price target on Medtronic, Inc. (NYSE: MDT) to $102.00 (from $110.00) while maintaining a Outperform rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

MDT Financial Forecast

MDT Earnings Forecast
Next quarter’s earnings estimate for MDT is $1.28 with a range of $1.25 to $1.44. The previous quarter’s EPS was $1.30. MDT beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.52% of the time in the same period. In the last calendar year MDT has Outperformed its overall industry.
Next quarter’s earnings estimate for MDT is $1.28 with a range of $1.25 to $1.44. The previous quarter’s EPS was $1.30. MDT beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.52% of the time in the same period. In the last calendar year MDT has Outperformed its overall industry.
MDT Sales Forecast
Next quarter’s sales forecast for MDT is $7.52B with a range of $7.46B to $7.77B. The previous quarter’s sales results were $7.58B. MDT beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 42.92% of the time in the same period. In the last calendar year MDT has Underperformed its overall industry.
Next quarter’s sales forecast for MDT is $7.52B with a range of $7.46B to $7.77B. The previous quarter’s sales results were $7.58B. MDT beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 42.92% of the time in the same period. In the last calendar year MDT has Underperformed its overall industry.
MDT Analyst Recommendation Trends
In the current month, MDT has received 5 Buy ratings 12 Hold ratings, and 1 Sell ratings. The MDT average analyst price target in the past 3 months is $87.50
In the current month, MDT has received 5 Buy ratings 12 Hold ratings, and 1 Sell ratings. The MDT average analyst price target in the past 3 months is $87.50

MDT Stock Forecast FAQ

What is MDT’s average 12-month price target, according to analysts?
Based on analyst ratings, Medtronic’s 12-month average price target is $87.50.
    What is MDT’s upside potential, based on the analysts’ average price target?
    Medtronic has 10.59% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is MDT a Buy, Sell or Hold?
          Medtronic has a conensus rating of Hold which is based on 5 buy ratings, 14 hold ratings and 1 sell ratings.
            What is Medtronic’s price target?
            The average price target for Medtronic is $87.50. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $102.00 ,the lowest forecast is $80.00. The average price target represents 10.59% Increase from the current price of $79.12.
              What do analysts say about Medtronic?
              Medtronic’s analyst rating consensus is a ‘Hold. This is based on the ratings of 20 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis